Skip to main content
. 2020 Sep 16;12(9):2636. doi: 10.3390/cancers12092636

Figure 1.

Figure 1

Consort diagram showing the selection criteria for phase three randomized control trials of metastatic solid tumor patients, with publications of their primary endpoints ultimately included in our analysis.